ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2710

Necrox-7 Inhibits Cell Aggressiveness By Suppressing of NF-Kappa B Activation and Reactive Oxygen Species Generation in Human Rheumatoid Arthritis Fibroblast-like Synoviocytes

Hyun Jung Yoo1,2, Jin Kyun Park2, Eun Young Lee2, Eun Bong Lee2 and Yeong Wook Song2,3, 1Department of Molecular Medicine and Biopharmaceutical Sciences, BK21 plus Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, 3Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine Seoul National University, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Antioxidants, Fibroblasts, pathogenesis, rheumatoid arthritis, signal transduction and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is characterized by hyperplastic synovial pannus tissue, which mediates destruction of cartilage and bone. Fibroblast-like synoviocytes (FLS) are a key component of the invasive pannus and have a major role in the initiation and perpetuation of destructive joint inflammation. NecroX-7 is a small chemical compound that exhibits cytoprotective effects and anti-oxidant activity. We investigated the inhibitory effects of NecroX-7 on the aggressiveness of TNF-α stimulated RA-FLS.

Methods: RA-FLS were cultured from synovial specimens obtained from RA patients undergoing joint replacement therapy. The cell viability was determined using CCK-8 colorimetric assay. The wound healing and transwell migration assay were performed to evaluate the effects of NecroX-7 on the migration of RA-FLS. Intracellular reactive oxygen species (ROS) generation was assessed by fluorometric assay. Matrix metalloproteinase-2 (MMP-2) and MMP-9 activity was measured using gelatin zymography. The expression of p-ERK1/2, p-p38, p-JNK and p-IκB was detected by Western blot analysis. The location of NF-κB p65 in RA-FLS was detected by immunofluorescence microscope.

Results: NecroX-7 had no significant cytotoxicity and inhibited migration of RA-FLS activated by TNF-α in vitro. NecroX-7 suppressed TNF-α-induced NF-κB activation by inhibiting ERK1/2 phosphorylation and IκB degradation and it prevented the nuclear translocation of NF-κB p65 with subsequent decrease in synthesis of MMP-2 and MMP-9. NecroX-7 reduced the generation of intracellular ROS (hydrogen peroxide, mitochondrial superoxide, cytosolic superoxide and peroxynitrite) in TNF-α-treated RA-FLS. 

Conclusion: NecroX-7 reduces activities of MMP-2 and MMP-9 via inhibition of NF-κB signaling pathway and intracellular ROS formation in activated RA-FLS, suggesting that NecroX-7 might suppress the aggressiveness of RA-FLS in vivo. NecroX-7 may provide a new therapeutic option in treatment of RA.


Disclosure: H. J. Yoo, None; J. K. Park, None; E. Y. Lee, None; E. B. Lee, None; Y. W. Song, None.

To cite this abstract in AMA style:

Yoo HJ, Park JK, Lee EY, Lee EB, Song YW. Necrox-7 Inhibits Cell Aggressiveness By Suppressing of NF-Kappa B Activation and Reactive Oxygen Species Generation in Human Rheumatoid Arthritis Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/necrox-7-inhibits-cell-aggressiveness-by-suppressing-of-nf-kappa-b-activation-and-reactive-oxygen-species-generation-in-human-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/necrox-7-inhibits-cell-aggressiveness-by-suppressing-of-nf-kappa-b-activation-and-reactive-oxygen-species-generation-in-human-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology